These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7344482)

  • 1. Role of reactive intermediates in halothane associated liver injury.
    Sipes IG; Gandolfi AJ
    Adv Exp Med Biol; 1981; 136 Pt A():603-18. PubMed ID: 7344482
    [No Abstract]   [Full Text] [Related]  

  • 2. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia.
    McLain GE; Sipes IG; Brown BR
    Anesthesiology; 1979 Oct; 51(4):321-6. PubMed ID: 484893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic necrosis caused by halothane and hypoxia in phenobarbital-treated rats.
    Ross WT; Daggy BP; Cardell RR
    Anesthesiology; 1979 Oct; 51(4):327-33. PubMed ID: 484894
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver injury following halothane anesthesia in phenobarbital-pretreated rats.
    Reynolds ES; Moslen MT
    Biochem Pharmacol; 1974 Jan; 23(2):189-95. PubMed ID: 4813340
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR; Waters SJ
    Anesth Analg; 1986 Aug; 65(8):835-9. PubMed ID: 3729018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of acute hepatic toxicity: chloroform, halothane, and glutathione.
    Brown BR; Sipes IG; Sagalyn AM
    Anesthesiology; 1974 Dec; 41(6):554-61. PubMed ID: 4433055
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of the immunological basis of halothane-induced hepatotoxicity.
    Satoh H; Gillette JR; Takemura T; Ferrans VJ; Jelenich SE; Kenna JG; Neuberger J; Pohl LR
    Adv Exp Med Biol; 1986; 197():657-73. PubMed ID: 3532710
    [No Abstract]   [Full Text] [Related]  

  • 8. Halothane hepatotoxicity: relation between metabolic activation, hypoxia, covalent binding, lipid peroxidation and liver cell damage.
    de Groot H; Noll T
    Hepatology; 1983; 3(4):601-6. PubMed ID: 6345332
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of oxygen concentration on the reaction of halothane with cytochrome P450 in liver microsomes and isolated perfused rat liver.
    Nastainczyk W; Ullrich V
    Biochem Pharmacol; 1978 Feb; 27(4):387-92. PubMed ID: 629799
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaerobic dehalogenation of halothane by reconstituted liver microsomal cytochrome P-450 enzyme system.
    Fujii K; Miki N; Sugiyama T; Morio M; Yamano T; Miyake Y
    Biochem Biophys Res Commun; 1981 Sep; 102(1):507-12. PubMed ID: 6796089
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
    Gruenke LD; Konopka K; Koop DR; Waskell LA
    J Pharmacol Exp Ther; 1988 Aug; 246(2):454-9. PubMed ID: 3404442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent binding of oxidative biotransformation reactive intermediates to protein influences halothane-associated hepatotoxicity in guinea pigs.
    Lind RC; Gandolfi AJ
    Adv Exp Med Biol; 1991; 283():763-6. PubMed ID: 2069053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phenobarbital pretreatment on the response of rat liver to halothane administration.
    Stenger RJ; Johnson EA
    Proc Soc Exp Biol Med; 1972 Sep; 140(4):1319-24. PubMed ID: 5057597
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of covalent binding from halothane metabolism in hepatic microsomes from phenobarbital-induced and hyperthyroid rats.
    Smith AC; Roberts SM; James RC; Berman LM; Harbison RD
    Xenobiotica; 1988 Aug; 18(8):991-1001. PubMed ID: 3188577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing halothane hepatotoxicity in the rat hypoxic model.
    Jee RC; Sipes IG; Gandolfi AJ; Brown BR
    Toxicol Appl Pharmacol; 1980 Feb; 52(2):267-77. PubMed ID: 6767300
    [No Abstract]   [Full Text] [Related]  

  • 16. Reductive metabolism of halothane by cytochrome P450 isoforms in rats and humans.
    Chow T; Imaoka S; Hiroi T; Funae Y
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):363-74. PubMed ID: 8896047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.
    Trudell JR; Bösterling B; Trevor AJ
    Mol Pharmacol; 1982 May; 21(3):710-7. PubMed ID: 7110119
    [No Abstract]   [Full Text] [Related]  

  • 18. The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450.
    Karashima D; Hirokata Y; Shigematsu A; Furukawa T
    J Pharmacol Exp Ther; 1977 Nov; 203(2):409-16. PubMed ID: 909072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halothane hepatotoxicity and reductive metabolism of halothane in acute experimental liver injury in rats.
    Nomura F; Hatano H; Iida S; Ohnishi K
    Anesth Analg; 1988 May; 67(5):448-52. PubMed ID: 3364763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halothane hepatotoxicity: enhancement by polychlorinated biphenyl pretreatment.
    Reynolds ES; Moslen MT
    Anesthesiology; 1977 Jul; 47(1):19-27. PubMed ID: 405890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.